Search research articles
Contact Us
Filters
Showing results (111-120 of 211) with videos related to
Page
of 22
Sort By:
Cancer Detection and Prevention
|
July 23, 1998
DNA repair enhancement by a combined supplement of carotenoids, nicotinamide, and zinc
Y Sheng, R W Pero, A R Olsson, et al.
Diabetologia
|
July 13, 2006
Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasis
B Ohlsson, O Melander, O Thorsson, et al.
Hepato-Gastroenterology
|
August 1, 1980
Natural protease inhibitors to fibrinolysis in liver diseases
R Arnman, E Gyzander, U Hedner, et al.
Diabetologia
|
May 7, 2005
Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts
C Kampf, T Lau, R Olsson, et al.
Alimentary Pharmacology & Therapeutics
|
October 4, 2006
Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic
M B De Valle, V Av Klinteberg, N Alem, et al.
Anesthesiology
|
February 7, 2001
The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium
E Sundman, H Witt, R Olsson, et al.
Journal of Hepatology
|
May 1, 1992
Liver damage from flucloxacillin, cloxacillin and dicloxacillin
R Olsson, B E Wiholm, C Sand, et al.
Clinical Pharmacokinetics
|
September 1, 1981
Pharmacokinetics of metoprolol in patients with hepatic cirrhosis
C G Regårdh, L Jordö, M Ervik, et al.
Journal of Clinical Microbiology
|
March 4, 2000
Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis
H O Nilsson, J Taneera, M Castedal, et al.
European Journal of Clinical Pharmacology
|
January 1, 1989
Pharmacokinetics of felodipine in patients with liver disease
C G Regårdh, B Edgar, R Olsson, et al.
Page
of 22
Search research articles
Search
Showing results (111-120 of 211) with videos related to
Sort By:
Page
of 22
Cancer Detection and Prevention
|
July 23, 1998
DNA repair enhancement by a combined supplement of carotenoids, nicotinamide, and zinc
Y Sheng, R W Pero, A R Olsson, et al.
Diabetologia
|
July 13, 2006
Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasis
B Ohlsson, O Melander, O Thorsson, et al.
Hepato-Gastroenterology
|
August 1, 1980
Natural protease inhibitors to fibrinolysis in liver diseases
R Arnman, E Gyzander, U Hedner, et al.
Diabetologia
|
May 7, 2005
Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts
C Kampf, T Lau, R Olsson, et al.
Alimentary Pharmacology & Therapeutics
|
October 4, 2006
Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic
M B De Valle, V Av Klinteberg, N Alem, et al.
Anesthesiology
|
February 7, 2001
The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium
E Sundman, H Witt, R Olsson, et al.
Journal of Hepatology
|
May 1, 1992
Liver damage from flucloxacillin, cloxacillin and dicloxacillin
R Olsson, B E Wiholm, C Sand, et al.
Clinical Pharmacokinetics
|
September 1, 1981
Pharmacokinetics of metoprolol in patients with hepatic cirrhosis
C G Regårdh, L Jordö, M Ervik, et al.
Journal of Clinical Microbiology
|
March 4, 2000
Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis
H O Nilsson, J Taneera, M Castedal, et al.
European Journal of Clinical Pharmacology
|
January 1, 1989
Pharmacokinetics of felodipine in patients with liver disease
C G Regårdh, B Edgar, R Olsson, et al.
Page
of 22